prr newsflow..., page-5

Maybe a relevant factor is the looming reductions to medicare subsidies as part of the expenditure review post debt-ceiling increase.

$10b reported as due to come off - mind you, that is from $520b allocated to it.

It may be having some affect on positive views formed about the likelihood of the US Govt forking out $60k per patient or whatever it will be for Cvac on the basis that Provenge got the nod after some spirited discussion.

Modern medicine still has to run the gauntlet of bean counters - there's only so many beans.

Not proposing that this will be a problem, only that it appears to reintroduce a bit of uncertainty in that respect that had been largely dipensed with before.

The market is amazing isn't it - falls because the debt ceiling isn't raised and then, when it is, it crashes further! Oh, to be one of the clever bunnies out there making a motza irrespective of what happens.

On the subject of PRR, they raised some capital when the going was good to fund their trials of a cancer treatment -seems reasonable to think that would be their primary goal, even if they are a corporation - well done to them.

Nasdaq has become PRR's very own 'N' word hasn't it?

It has probably reached the stage where they ought to make some public reference to it, even just say the process is still underway, even if just to dispell the 'sturm und drang' that is filling the vacuum.

They must appreciate that holders get a bit more excited than they do in the office, where I guess it is not such a fixation - even leaving aside that they will know the current status of the application.

And another thing, they did hire an expert in these matters to shepherd it through the process didn't they? Hope they are being billed as a single task and not by the hour...